ArticleCureus2025
Effectiveness of Transurethral Resection of the Prostate in Managing Lower Urinary Tract Symptoms and Enhancing Quality of Life: A Prospective South Indian Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benign prostatic hyperplasia (BPH) is a non-malignant enlargement of the prostate in elderly men, commonly causing lower urinary tract symptoms (LUTS) that significantly impair quality of life (QoL). Although laser enucleation techniques are increasingly adopted, transurethral resection of the prostate (TURP) remains a widely used standard treatment. This study evaluates the clinical effectiveness of TURP in alleviating LUTS and enhancing QoL. A prospective study was conducted at a tertiary care hospital in South India from March to August 2024. Fifty male patients aged 45-85 years, diagnosed with BPH, underwent TURP. Symptom severity and functional outcomes were assessed using the International Prostate Symptom Score (IPSS), Index of Quality of Life (IQL) score, post-void residual (PVR) urine, and uroflowmetry preoperatively and at four, eight, and 12 weeks postoperatively. Data were analysed using paired-sample t-tests. The mean patient age was 60.7 years. Baseline IPSS was 25.1 ± 6.8, and IQL was 4.5 ± 0.9. Postoperatively, IPSS improved significantly to 16.5 ± 4.5 at four weeks and 5.8 ± 3.0 at 12 weeks. IQL remained at 4.5 ± 1.0 at four weeks but significantly improved to 1.1 ± 0.9 by 12 weeks. PVR and uroflowmetry values also showed statistically significant improvement (p < 0.001). TURP offers substantial early and sustained relief from LUTS and significantly enhances QoL in patients with moderate to severe BPH, maintaining its relevance despite the growing use of laser techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.